Cancer Data Science Pulse

Data Sharing

Learn more about new streamlined access to broad-use data sets within the database of Genotypes and Phenotypes (dbGaP).

As NCI recognizes Breast Cancer Awareness Month this October, we highlight several data science resources to assist in your breast cancer research.

Do you know how the 2023 NIH Data Management and Sharing Policy will impact your work? If you are seeking NCI funding, this blog is for you. We cover the key policy distinctions, implementation changes, and resources to help you navigate the process.

Looking for ways to visualize your data? We asked data scientists to show us their favorite visualizations. Here, Dr. Alida Palmisano of NCI's Computational and Systems Biology Branch shares her ideas for visualizing complex single-cell RNA sequencing data.

This year’s theme for World Cancer Research Day is “support research to prevent cancer and catch it early.” How can data science drive progress in international cancer research? Check out our NCI resources and learn what we have to support those global research efforts.

Watch our time capsule video to learn about the current status of the field and new technologies that are sure to be important as we embark on the next era of cancer data research.

As NCI recognizes Childhood Cancer Awareness Month this September, we highlight a list of data science resources and tools to aid your pediatric cancer research.

Discover how NIH is working to make generalist repositories (GRs) part of the data sharing ecosystem. The goal is to minimize data sharing barriers while still taking advantage of GR convenience and usability.

Data and Artificial Intelligence (AI) are a match seemingly made in heaven. By joining data and AI, scientists are able to shift a lot of the burden associated with using data from human to machine. See why the data-AI relationship works so well for cancer research in this offbeat blog featuring two fictitious characters—Datum and his pal Aida.

At the start of the COVID-19 outbreak, NCI’s Frederick National Laboratory for Cancer Research, along with the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases, modified an existing tool used for managing NCI’s clinical trials to create a COVID-19 Seroprevalence Hub (SeroHub) to track COVID-19 seroprevalence across the United States. This blog looks at how SeroHub has evolved since the pandemic first began and shows how it could serve as a blueprint for monitoring future infectious disease outbreaks that threaten public health.